Pharmacogenetics: the slow, the rapid, and the ultrarapid.
about
Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancerPharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Pharmacogenetics and psychopharmacotherapy.Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants.Human CYPs: in vivo and clinical aspects.CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.Addressing phenoconversion: the Achilles' heel of personalized medicine.Pharmacogenomics: marshalling the human genome to individualise drug therapyPharmacogenetics and the treatment of functional gastrointestinal disorders.CYP2D6 Genetic Polymorphisms and Phenotypes in Different Ethnicities of Malaysian Breast Cancer Patients.Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer.Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance.Antidepressants and drug-metabolizing enzymes--expert group report.Overview of enzymes of drug metabolism.Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility.Polymorphic variation of CYP1A1 and CYP1B1 genes in a Haryana population.Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis.CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population.
P2860
Q33608783-E533443D-B3B2-477F-B98C-01E521149392Q33818189-1E770472-572D-47CE-90ED-D318EFB0B357Q33962212-57F1F126-EF9A-437D-92CD-E0CF36D30498Q34093080-579468BC-1F7E-4067-8708-0DBAF2667A71Q34627903-A04F0178-CE20-4F1C-AC19-C6FE80AC1AB4Q34744094-E36EAA55-8498-47AF-B911-9354763B92F4Q35023701-A1277DF7-57F5-4875-966D-151E1BB0142AQ35090217-72323DE1-E4B0-48CE-AD06-A2CD5C11D746Q38661352-218A3A45-D366-490D-BD1D-8F3390BE17E4Q40382805-007F013C-A9B1-4B8E-91A0-B04AC2916B33Q40848904-D69D5A98-2557-4E96-B40D-0F7D62ABB309Q40902474-19E9032B-C902-4DFD-9C0E-793B44F9AB21Q41019100-3A66018D-A80E-45B9-BD75-FA23DE87E156Q41456093-C389C4AF-6188-41DB-AFAA-AE90139610A9Q43071574-67C6E5D4-296F-43BD-819C-7D300798F25EQ43109060-91A62F36-98E5-4B59-86A8-32E090B5FEC5Q50600844-E736DE6B-AB48-4AF6-811C-7058C210F38FQ50848251-85DC65E4-616D-4D54-969C-C88246A26C23Q51385249-2951F023-E290-4105-A4F4-36BCFF14A831Q53176616-46F53E8B-8067-45FF-9D4F-90E17373DB68
P2860
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
@ast
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
@en
type
label
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
@ast
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
@en
prefLabel
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
@ast
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
@en
P2860
P356
P1476
Pharmacogenetics: the slow, the rapid, and the ultrarapid.
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.6.1983
P407
P577
1994-03-01T00:00:00Z